Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCADE
2015-001065-76Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan in Ehlers-Danlos syndrome (EDS), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2015; status: completed.
02
Drugs
irbesartan
03
Conditions
Ehlers-Danlos syndrome (EDS)
Beyond the preview
Go deeper on 2015-001065-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001065-76.